1080-P: Continuous Glucose Monitor Integration into Primary Care Clinics

Introduction 18yo with A1c 8% without past CGM use or an endocrinology visit in the past year. Patients saw a Diabetes Care and Education Specialist (DCES) and/or a pharmacist (PharmD) for diagnostic CGM placement and education on nutrition, medication administration, and physical activity goals. DCES or PharmD reviewed the data with patients and sent recommendations to the PCP. Individuals with data post-intervention for A1c and time in range (TIR) were included. Results: CGM users (n=41) were mean (SD) 62.05 (14.54) years of age and 26.83% female. TIR increased by 29.13% from 42.31% (33.25) at baseline to 71.44% (25.79) at 3 months (p 0.001), due to reduced hyperglycemia (Table 1). The proportion of CGM users meeting the consensus target of TIR ≥70% increased from 21.95% to 58.54% (p0.001). Post-intervention, A1c decreased 2.45% from 9.62 (1.65) to 7.17 (1.08) (p0.001). Conclusion: Integration of CGM into primary care clinics is feasible and effective using a multidisciplinary approach. Disclosure A. Zadel: None. K. Chiampas: None. K. Maktaz: None. M.J. Eimer: Stock/Shareholder; Agitated Solutions. J.G. Keller: None. E. Szmuilowicz: None. K.W. O'Gara: None. Funding Northwestern Medicine North Region Quality and Innovation Funds Award